Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype

BACKGROUND: Metaplastic breast cancer (MBC) is a rare and aggressive subtype of the breast. To understand the characteristics and prognosis of single hormone receptor-positive (HR+) MBC (estrogen receptor-positive [ER+]/progesterone receptor-negative [PR-] and ER-/PR+), we compared these tumors to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Jinqian, Hu, Jin, Zhang, Yanting, Shen, Jian, Dong, Fang, Zhang, Ximeng, Ming, Jie, Huang, Tao, Run, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105402/
https://www.ncbi.nlm.nih.gov/pubmed/33972826
http://dx.doi.org/10.3389/fendo.2021.628939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105402/
https://www.ncbi.nlm.nih.gov/pubmed/33972826
http://dx.doi.org/10.3389/fendo.2021.628939

Ejemplares similares